New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
16:32 EDTTRNXTornier names David H. Mowry CEO
Tornier announced that its board has appointed David H. Mowry as president and CEO, effective immediately. Mowry joined Tornier in July 2011 as COO.
News For TRNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
09:56 EDTTRNXIntegra deal with Tornier a win for both, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said he views Integra LifeSciences' (IART) acquisition of Tornier's (TRNX) U.S. ankle replacement and silastic toe replacement products as a "win win" for both companies. O'Brien estimates a deal price between $25M-$35M, saying he believes Integra gets a "quality total ankle system at an attractive price," while adding that Tornier clears the last hurdle with the FTC for its Wright Medical (WMGI) deal with the divestiture. O'Brien maintains his Overweight rating and $72 price target on Integra shares.
05:34 EDTTRNXIntegra LifeSciences to acquire Salto Talaris, Salto XT from Tornier
Subscribe for More Information
September 2, 2015
07:54 EDTTRNXWright Medical approval one of two main catalysts, says Leerink
Leerink analyst Richard Newitter views the FDA approval of Augment as one of two main upcoming catalysts for Wright Medical (WMGI). The second is the Tornier (TRNX) deal closing, which the analyst thinks could also occur this quarter. Newitter says an overhang has been removed with the approval and reiterates an Outperform rating on Wright with a $31 price target.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use